At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,000 enrolled
Drug / intervention
patientsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
In Brief
An observational study evaluating patients for Sarcoma, Ewing. Completed, enrolled 1,000 participants across 1 site.
Detailed Summary
Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoma, Ewing
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartApr 2021
Primary CompletionJul 2021
First PostedOct 2021
TodayJul 2026
First PostedOct 29, 2021
Enrollment StartApr 2, 2021
Primary CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.7 years ago
Interventions
patientsother
Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis